Understanding Secondary Immunodeficiency
Immunodeficiency disorders are associated with, or predispose individuals to, various complications, including infections, autoimmune disorders, and lymphomas and other cancers. Primary immunodeficiencies are genetically determined and can be hereditary, and secondary immunodeficiencies are acquired and much more common. This activity will identify those at risk for immunodeficiency disorders and their manifestations, as well as discuss models of care for the treatment and management of primary and secondary immunodeficiency.
This activity is provided by OptumHealth Education.
This activity is supported by OptumCare.
To view this activity you will need Internet Explorer 7.0+ or Firefox 3.0+ with Windows Media Player 9+, RealPlayer 12+ or Adobe Flash Player 9+. Be sure to disable any pop-up blocking software prior to beginning this activity.
This activity is designed to meet the educational needs of physicians — including family physicians — coders and other health care professionals interested in immunodeficiency.
At the end of this educational activity, participants should be able to
- Identify who is at risk for primary immunodeficiency and secondary immunodeficiency syndrome.
- Discuss the different ways that immunodeficiency can present itself.
- Explain how to manage individuals with immunodeficiency both acutely and/or prophylactically.
- Describe how protein calorie malnutrition (PCM) is associated with immunodeficiency.
Mark R. Schleiss, MD
University of Minnesota Medical School
About the presenter
Mark R. Schleiss, MD, received his medical degree from the Oregon Health and Sciences University, Portland, Ore. He completed his residency at Doernbecher Children’s Hospital, Oregon Health and Sciences University, Portland and his pediatric infectious diseases fellowship at Children’s Hospital Medical Center, University of Washington, Seattle, Wash. He also completed a fellowship in molecular medicine studying cytomegalovirus molecular genetics at the Fred Hutchinson Cancer Research Center, Seattle.
Dr. Schleiss is engaged in the study of CMV vaccines, immunopathogenesis and placental infection. Using a variety of vaccine strategies, including purified protein subunit and DNA vaccines, his lab is evaluating the extent of protection of the maternal-placental-fetal unit against CMV infection and disease, using animal models of infection. These studies integrate molecular virology with immunological endpoints to understand in greater detail the aspects of the maternal immune response that are critical in protection of the fetus. Translational research is examining the feasibility of establishing newborn screening programs for congenital CMV infection.
Sarah Chart, RN
Eden Prairie, MN
Rebecca Gleason, RN, CCM
Eden Prairie, MN
Kevin Heath, MD, MHL, FACP
Medical Director, Clinical Performance
Disclosures of relevant financial relationships
In accordance with the ACCME Standards for Commercial SupportSM, OptumHealth Education (OHE) requires all those involved in the development of activity content to disclose their relevant financial relationships. An individual has a relevant financial relationship if such person (or his/her spouse/partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest. OHE ensures that the content is independent of commercial bias.
Ms. Chart and Ms. Gleason have indicated that they are employees of and own stock in UnitedHealth Group.
The remaining activity faculty or planners have no financial relationships to disclose.
Method for calculating CE credit
CE credit was calculated by the complexity of content.
In support of improving patient care, OptumHealth Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
Credit Designation Statements
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts credit from organizations accredited by the ACCME and ANCC.
OptumHealth Education designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Academy of Family Physicians
This Enduring Material activity, Understanding Secondary Immunodeficiency, has been reviewed and is acceptable for up to 1.00 Elective credit(s) by the American Academy of Family Physicians. AAFP certification begins April 22, 2019. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Academy of Physician Assistants (AAPA) accepts credit from organizations accredited by the ACCME.
This program meets AAPC guidelines for 1.0 CEU. Can be used for Core A, CANPC and CHONC with successful completion of post-test for continuing education units.
A certificate of attendance will be provided to learners upon completion of activity requirements, enabling participants to register with licensing boards or associations that have not been pre-approved for credits. To apply for credit types not listed above, participants should use the procedure established by the specific organization with which they wish to obtain credit.
- 1.00 AAPC
- 1.00 AMA
- 1.00 Attendance
You must be logged into your account to participate in this activity. Get started by clicking “Continue” and viewing the “CE Info”; then follow the prompts at the bottom of the screen. At the end of the activity, you will be able to view, save or print your certificate of participation. A complete listing of all of your activities can be found under “My Account”, “My Activities.”